Throughout the human body, in virtually every tissue and organ, white…
Category: Gene Interference
Home /
RNA editing is emerging as a promising and potentially safer alternative…
Although mosquitoes measure less than an inch and weigh a mere…
RNA-based vaccines have achieved superstar status and Nobel Prize recognition. Now,…
A man in Germany has been cleared of human immunodeficiency virus…
Thanks in large part to the efficacy of the Pfizer-BioNTech and…
Within every hair follicle are the stem cells programmed to grow…
Lyme disease is the most commonly reported tick-borne illness in the…
While research on potential therapeutic applications of mRNA has been underway…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
Torching Cancer Using Tumors’ Own Immune Cells
February 9, 2026
Throughout the human body, in virtually every tissue and organ, white blood cells called macrophages are waging a constant battle. These hardworking immune cells destroy
RNA Editing: A Safer Alternative in Genetic Medicine?
June 17, 2024
RNA editing is emerging as a promising and potentially safer alternative to therapies that modify an individual’s DNA. In December 2023, patients were treated in
Pharma’s Expanding Arsenal Against Mosquitoes — the World’s Deadliest Creatures
January 29, 2024
Although mosquitoes measure less than an inch and weigh a mere 2.5 milligrams, the disease burdens they carry make them the “deadliest animal on Earth,”
It’s Going Around — Biotechs Bet on Circular RNA’s Therapeutic Potential
January 15, 2024
RNA-based vaccines have achieved superstar status and Nobel Prize recognition. Now, several biotechnology firms are considering circular RNAs (circRNAs) as a platform for therapeutic development,
Third Patient Cured of HIV After Stem Cell Transplant
April 17, 2023
A man in Germany has been cleared of human immunodeficiency virus (HIV), according to researchers, after receiving a stem cell transplant from an HIV-resistant donor.
The Potential of a Self-Amplifying mRNA Vaccine Is Heard Loud and Clear
June 13, 2022
Thanks in large part to the efficacy of the Pfizer-BioNTech and Moderna mRNA vaccines, mask mandates, social distancing, and other COVID-19-related precautions have eased in
Stem Cells May Be at the Root of Baldness – As Well As the Cure
May 23, 2022
Within every hair follicle are the stem cells programmed to grow hair. These cells inhabit and grow in a region of the follicle called the
A Novel Approach to a New mRNA-Based Lyme Disease Vaccine: Tick Saliva
January 17, 2022
Lyme disease is the most commonly reported tick-borne illness in the United States and the worldwide burden of Lyme disease has increased in recent years,
mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19 vaccines
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…